Cost-effectiveness evaluation of linezolid, vancomycin and teicoplanin in treating nosocomial pneumonia caused by methicilin resistant staphylococcus aureus (mrsa) – Private health care system perspective
May 1, 2013, 00:00
10.1016/j.jval.2013.03.411
https://www.valueinhealthjournal.com/article/S1098-3015(13)00482-8/fulltext
Title :
Cost-effectiveness evaluation of linezolid, vancomycin and teicoplanin in treating nosocomial pneumonia caused by methicilin resistant staphylococcus aureus (mrsa) – Private health care system perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00482-8&doi=10.1016/j.jval.2013.03.411
First page :
A88
Section Title :
Infection
Open access? :
No
Section Order :
1449